Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| RESMED INCRMD · Entity 2692 | Director | November 01, 2019 | November 05, 2019 |
| STERIS plcSTE · Entity 158792 | Director | August 09, 2017 | August 11, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
RESMED INC
Report date November 01, 2019 · Filed November 05, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| ResMed Common StockSEC Table I · non-derivative | Direct | 11,300 |
Ending reported balance
After 2019-11-04 transaction · row 7
7 source rows · reconciled sequenceRow 1 · 2019-11-01 · Exercise / conversion · Acquired 9,536 · Balance 21,936 Row 2 · 2019-11-01 · Sale · Disposed 9,536 · Balance 12,400 F1: This transaction was executed in multiple trades at prices ranging from $148.00 to $148.52. The price reported above reflects the weighted average sale price. Row 3 · 2019-11-04 · Exercise / conversion · Acquired 5,000 · Balance 17,400 Row 4 · 2019-11-04 · Sale · Disposed 5,000 · Balance 12,400 Row 5 · 2019-11-04 · Exercise / conversion · Acquired 5,956 · Balance 18,356 Row 6 · 2019-11-04 · Sale · Disposed 5,956 · Balance 12,400 Row 7 · 2019-11-04 · Gift · Disposed 1,100 · Balance 11,300 F2: Gift of shares to Washington University in St. Louis. Mr. Wareham has no beneficial interest, control or dispositive power over the gifted shares. |
| ResMed Common Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $58.24 · Expires 2022-11-19 | Direct | 10,956 |
Reported balance
After 2019-11-01 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2019-11-01 · Exercise / conversion · Disposed 9,536 · Balance 10,956 |
| ResMed Common Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $58.24 · Expires 2022-11-19 | Direct | 5,956 |
Reported balance
After 2019-11-04 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2019-11-04 · Exercise / conversion · Disposed 5,000 · Balance 5,956 |
| ResMed Common Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $58.24 · Expires 2022-11-19 | Direct | 0 |
Reported balance
After 2019-11-04 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2019-11-04 · Exercise / conversion · Disposed 5,956 · Balance 0 |
Filing footnotes · ownership attribution and instrument terms
F1: This transaction was executed in multiple trades at prices ranging from $148.00 to $148.52. The price reported above reflects the weighted average sale price.
F2: Gift of shares to Washington University in St. Louis. Mr. Wareham has no beneficial interest, control or dispositive power over the gifted shares.
STERIS plc
Report date August 09, 2017 · Filed August 11, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $86.23 · Expires 2027-08-09 | Direct | 5,450 |
Reported balance
After 2017-08-09 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2017-08-09 · Grant · Acquired 5,450 · Balance 5,450 F1: These nonqualified stock options are fully vested and are exercisable immediately. |
| Career Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 8,360 |
Reported balance
After 2017-08-09 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2017-08-09 · Grant · Acquired 1,362 · Balance 8,360 F2: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F3: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. |
Filing footnotes · ownership attribution and instrument terms
F1: These nonqualified stock options are fully vested and are exercisable immediately.
F2: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service.
F3: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 04, 2019 Filed Nov 5, 2019 19:57 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock Options · Derivative | 5,956 | $0.00 Strike: $58.24 | $0.00 |
DisclosureSEC source: 0001127602-19-031852 · form4.xml · derivative · entry 10 WAREHAM JOHN P · CIK 0001231182 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: ResMed Commmon Stock · 5,956 shares Expires 2022-11-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 04, 2019 Filed Nov 5, 2019 19:57 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock Options · Derivative | 5,000 | $0.00 Strike: $58.24 | $0.00 |
DisclosureSEC source: 0001127602-19-031852 · form4.xml · derivative · entry 9 WAREHAM JOHN P · CIK 0001231182 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,956 Underlying: ResMed Commmon Stock · 5,000 shares Expires 2022-11-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 04, 2019 Filed Nov 5, 2019 19:57 UTC | RESMED INC RMD · Entity 2692 | GiftResMed Common Stock | 1,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-031852 · form4.xml · nonDerivative · entry 7 WAREHAM JOHN P · CIK 0001231182 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,300 F2 · kind: Gift of shares to Washington University in St. Louis. Mr. Wareham has no beneficial interest, control or dispositive power over the gifted shares. Read SEC document |
| November 04, 2019 Filed Nov 5, 2019 19:57 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 5,956 | $148.00 | $881,488.00 |
DisclosureSEC source: 0001127602-19-031852 · form4.xml · nonDerivative · entry 6 WAREHAM JOHN P · CIK 0001231182 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,400 Read SEC document |
| November 04, 2019 Filed Nov 5, 2019 19:57 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock | 5,956 | $58.24 | $346,877.44 |
DisclosureSEC source: 0001127602-19-031852 · form4.xml · nonDerivative · entry 5 WAREHAM JOHN P · CIK 0001231182 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,356 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 04, 2019 Filed Nov 5, 2019 19:57 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 5,000 | $147.75 | $738,750.00 |
DisclosureSEC source: 0001127602-19-031852 · form4.xml · nonDerivative · entry 4 WAREHAM JOHN P · CIK 0001231182 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,400 Read SEC document |
| November 04, 2019 Filed Nov 5, 2019 19:57 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock | 5,000 | $58.24 | $291,200.00 |
DisclosureSEC source: 0001127602-19-031852 · form4.xml · nonDerivative · entry 3 WAREHAM JOHN P · CIK 0001231182 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,400 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 01, 2019 Filed Nov 5, 2019 19:57 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock Options · Derivative | 9,536 | $0.00 Strike: $58.24 | $0.00 |
DisclosureSEC source: 0001127602-19-031852 · form4.xml · derivative · entry 8 WAREHAM JOHN P · CIK 0001231182 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,956 Underlying: ResMed Commmon Stock · 9,536 shares Expires 2022-11-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 01, 2019 Filed Nov 5, 2019 19:57 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 9,536 | $148.15 | $1,412,729.79 |
DisclosureSEC source: 0001127602-19-031852 · form4.xml · nonDerivative · entry 2 WAREHAM JOHN P · CIK 0001231182 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,400 F1 · price: This transaction was executed in multiple trades at prices ranging from $148.00 to $148.52. The price reported above reflects the weighted average sale price. Read SEC document |
| November 01, 2019 Filed Nov 5, 2019 19:57 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock | 9,536 | $58.24 | $555,376.64 |
DisclosureSEC source: 0001127602-19-031852 · form4.xml · nonDerivative · entry 1 WAREHAM JOHN P · CIK 0001231182 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,936 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 30, 2019 Filed Aug 2, 2019 01:55 UTC | RESMED INC RMD · Entity 2692 | GiftResMed Common Stock | 600 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-025751 · form4.xml · nonDerivative · entry 1 WAREHAM JOHN P · CIK 0001231182 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,400 F1 · kind: Gift of shares to the City of Hope and the Big Brothers Big Sisters 501(c)(3) organizations. Mr. Wareham has no beneficial interest, control or dispositive power over the gifted shares. Read SEC document |
| May 24, 2019 Filed May 28, 2019 20:37 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock Options · Derivative | 23,629 | $0.00 Strike: $52.02 | $0.00 |
DisclosureSEC source: 0001127602-19-020022 · form4.xml · derivative · entry 9 WAREHAM JOHN P · CIK 0001231182 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: ResMed Commmon Stock · 23,629 shares Expires 2021-11-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Represents date options first became exercisable. Options vest on the earlier of (i) the first November 11 following the Grant Date, or (ii) the date of the first (1st) annual meeting of stockholders of the Company following the Grant Date. Read SEC document |
| May 24, 2019 Filed May 28, 2019 20:37 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock Options · Derivative | 9,628 | $0.00 Strike: $51.25 | $0.00 |
DisclosureSEC source: 0001127602-19-020022 · form4.xml · derivative · entry 8 WAREHAM JOHN P · CIK 0001231182 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: ResMed Common Stock · 9,628 shares Expires 2020-11-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Represents date options first became exercisable. Options vest on the earlier of (i) the first November 11 following the Grant Date, or (ii) the date of the first (1st) annual meeting of stockholders of the Company following the Grant Date. Read SEC document |
| May 24, 2019 Filed May 28, 2019 20:37 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock Options · Derivative | 11,085 | $0.00 Strike: $51.25 | $0.00 |
DisclosureSEC source: 0001127602-19-020022 · form4.xml · derivative · entry 7 WAREHAM JOHN P · CIK 0001231182 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,628 Underlying: ResMed Common Stock · 11,085 shares Expires 2020-11-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Represents date options first became exercisable. Options vest on the earlier of (i) the first November 11 following the Grant Date, or (ii) the date of the first (1st) annual meeting of stockholders of the Company following the Grant Date. Read SEC document |
| May 24, 2019 Filed May 28, 2019 20:37 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 23,629 | $114.00 | $2,693,706.00 |
DisclosureSEC source: 0001127602-19-020022 · form4.xml · nonDerivative · entry 6 WAREHAM JOHN P · CIK 0001231182 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,000 Read SEC document |
| May 24, 2019 Filed May 28, 2019 20:37 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock | 23,629 | $52.02 | $1,229,180.58 |
DisclosureSEC source: 0001127602-19-020022 · form4.xml · nonDerivative · entry 5 WAREHAM JOHN P · CIK 0001231182 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,629 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 24, 2019 Filed May 28, 2019 20:37 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 9,628 | $114.00 | $1,097,592.00 |
DisclosureSEC source: 0001127602-19-020022 · form4.xml · nonDerivative · entry 4 WAREHAM JOHN P · CIK 0001231182 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,000 Read SEC document |
| May 24, 2019 Filed May 28, 2019 20:37 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock | 9,628 | $51.25 | $493,435.00 |
DisclosureSEC source: 0001127602-19-020022 · form4.xml · nonDerivative · entry 3 WAREHAM JOHN P · CIK 0001231182 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,628 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 24, 2019 Filed May 28, 2019 20:37 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 11,085 | $113.44 | $1,257,426.98 |
DisclosureSEC source: 0001127602-19-020022 · form4.xml · nonDerivative · entry 2 WAREHAM JOHN P · CIK 0001231182 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,000 F1 · price: This transaction was executed in multiple trades at prices ranging from $113.44 to $113.45. The price reported above reflects the weighted average sale price. Read SEC document |
| May 24, 2019 Filed May 28, 2019 20:37 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock | 11,085 | $51.25 | $568,106.25 |
DisclosureSEC source: 0001127602-19-020022 · form4.xml · nonDerivative · entry 1 WAREHAM JOHN P · CIK 0001231182 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,085 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 14, 2018 Filed Nov 17, 2018 00:37 UTC | RESMED INC RMD · Entity 2692 | GrantResMed Common Stock Options · Derivative | 11,442 | $0.00 Strike: $101.64 | $0.00 |
DisclosureSEC source: 0001567619-18-006568 · doc1.xml · derivative · entry 2 WAREHAM JOHN P · CIK 0001231182 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,442 Underlying: ResMed Commmon Stock · 11,442 shares Expires 2025-11-14 F1 · derivative.exercise_date: Options vest in full (i) on the first Nov. 11 following the grant date or (ii) the first annual shareholders meeting following grant date. Read SEC document |
| January 26, 2018 Filed Jan 29, 2018 17:51 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResmed Common Stock Options · Derivative | 25,934 | $0.00 Strike: $38.98 | $0.00 |
DisclosureSEC source: 0001140361-18-003498 · doc1.xml · derivative · entry 4 WAREHAM JOHN P · CIK 0001231182 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: ResMed Commmon Stock · 25,934 shares Expires 2019-11-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Represents the date options became exercisable. Options vest in full (i) on the first Nov. 11 following the grant date or (ii) the first annual shareholders meeting following grant date. Read SEC document |
| January 26, 2018 Filed Jan 29, 2018 17:51 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 8,300 | $102.60 | $851,580.00 |
DisclosureSEC source: 0001140361-18-003498 · doc1.xml · nonDerivative · entry 3 WAREHAM JOHN P · CIK 0001231182 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,000 F2 · price: This transaction was executed in multiple trades at prices ranging from $102.49 to $102.73. The price reported above reflects the weighted average sale price. Read SEC document |
| January 26, 2018 Filed Jan 29, 2018 17:51 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 17,634 | $102.09 | $1,800,255.06 |
DisclosureSEC source: 0001140361-18-003498 · doc1.xml · nonDerivative · entry 2 WAREHAM JOHN P · CIK 0001231182 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,300 F1 · price: This transaction was executed in multiple trades at prices ranging from $101.49 to $102.49. The price reported above reflects the weighted average sale price. Read SEC document |
| January 26, 2018 Filed Jan 29, 2018 17:51 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock | 25,934 | $38.98 | $1,010,907.32 |
DisclosureSEC source: 0001140361-18-003498 · doc1.xml · nonDerivative · entry 1 WAREHAM JOHN P · CIK 0001231182 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,934 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 16, 2017 Filed Nov 20, 2017 18:50 UTC | RESMED INC RMD · Entity 2692 | GrantResMed Common Stock Options · Derivative | 15,115 | $0.00 Strike: $84.98 | $0.00 |
DisclosureSEC source: 0001140361-17-043340 · doc1.xml · derivative · entry 2 WAREHAM JOHN P · CIK 0001231182 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,115 Underlying: ResMed Commmon Stock · 15,115 shares Expires 2024-11-16 F1 · derivative.exercise_date: Options vest in full (i) on the first Nov. 11 following the grant date or (ii) the first annual shareholders meeting following grant date. Read SEC document |
| August 09, 2017 Filed Aug 11, 2017 16:47 UTC | STERIS plc STE · Entity 158792 | GrantCareer Restricted Stock Units · Derivative | 1,362 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-048614 · doc4.xml · derivative · entry 2 WAREHAM JOHN P · CIK 0001231182 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,360 Underlying: Ordinary Shares · 1,362 shares Expires not disclosed F2 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F3 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F3 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document |
| August 09, 2017 Filed Aug 11, 2017 16:47 UTC | STERIS plc STE · Entity 158792 | GrantDirector Stock Option (right to buy) · Derivative | 5,450 | $0.00 Strike: $86.23 | $0.00 |
DisclosureSEC source: 0001209191-17-048614 · doc4.xml · derivative · entry 1 WAREHAM JOHN P · CIK 0001231182 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,450 Underlying: Ordinary Shares · 5,450 shares Expires 2027-08-09 F1 · derivative.exercise_date: These nonqualified stock options are fully vested and are exercisable immediately. Read SEC document |
| February 24, 2017 Filed Feb 28, 2017 21:36 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock Options · Derivative | 28,403 | $0.00 Strike: $27.58 | $0.00 |
DisclosureSEC source: 0001140361-17-009665 · doc1.xml · derivative · entry 3 WAREHAM JOHN P · CIK 0001231182 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: ResMed Commmon Stock · 28,403 shares Expires 2018-11-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Represents date options first became exercisable. Read SEC document |
| February 24, 2017 Filed Feb 28, 2017 21:36 UTC | RESMED INC RMD · Entity 2692 | SaleResMed Common Stock | 28,403 | $71.77 | $2,038,454.91 |
DisclosureSEC source: 0001140361-17-009665 · doc1.xml · nonDerivative · entry 2 WAREHAM JOHN P · CIK 0001231182 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,000 F1 · price: This transaction was executed in multiple trades at prices ranging from $71.64 to $71.91. The price reported above reflects the weighted average sale price. Read SEC document |
| February 24, 2017 Filed Feb 28, 2017 21:36 UTC | RESMED INC RMD · Entity 2692 | Exercise / conversionResMed Common Stock | 28,403 | $27.58 | $783,354.74 |
DisclosureSEC source: 0001140361-17-009665 · doc1.xml · nonDerivative · entry 1 WAREHAM JOHN P · CIK 0001231182 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,403 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 16, 2016 Filed Nov 18, 2016 01:53 UTC | RESMED INC RMD · Entity 2692 | GrantResMed Common Stock Options · Derivative | 23,277 | $0.00 Strike: $57.76 | $0.00 |
DisclosureSEC source: 0001140361-16-087149 · doc1.xml · derivative · entry 2 WAREHAM JOHN P · CIK 0001231182 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,277 Underlying: ResMed Commmon Stock · 23,277 shares Expires 2023-11-16 F1 · derivative.exercise_date: Options vest in full on the first November 11 following the grant date, or the first annual shareholders meeting following grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.